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Two nitrofuran compounds, nifurtimox and nitrofurantoin, inhibited in a concentration-dependent manner 
the NADPH-, iron-induced lipid peroxidation in rat liver microsomes, as shown by the decreased rate of 
MDA accumulation. Other nitro compounds (benznidazole and chloramphenicol) were relatively inactive. 
Nifurtimox inhibition affected polyenoic fatty acids and cytochrome P-450 degradation that follows lipid 
peroxidation. The ascorbate- or tert-butyl hydroperoxide-dependent lipid peroxidations were much less in- 
hibited than the NADPH-dependent one. Nifurtimox and nitrofurantoin, but not benznidazole and chlor- 
amphenicol, strongly stimulated the microsomal NADPH-oxidase activity, thus supporting electron diver- 
sion, as the main cause of the inhibition of peroxidation initiation. 
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1. INTRODUCTION 
One of the toxic consequences of oxidative stress 
in cells would be expected to be lipid peroxidation, 
initiated by active oxygen species [l] but, paradox- 
ically, some oxyradical generators, such as 
quinones are also powerful antioxidants [2-41. In 
the present study we have examined several nitro 
compounds (nifurtimox, nitrofurantoin, benz- 
nidazole and chloramphenicol) for their action on 
lipid peroxidation in rat liver microsomes. It is 
known that redox cycling of nitro compounds, 
especially nifurtimox and benznidazole, generates 
nitroanions and oxyradicals [5-71. Nifurtimox and 
benznidazole are drugs extensively used for the 
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treatment of American trypanosomiasis (Chagas’ 
disease). 
2. MATERIALS AND METHODS 
2.1. Microsomal preparations 
Microsomes were obtained from the livers of 
20 h fasted, male Wistar rats, 240-280 g, fed a 
Purine-like rat chow. The homogenate was 
prepared as in [8] and the microsomal fraction as 
in [6]. The pellet was resuspended in 150 mM KC1 
and used immediately for the peroxidation ex- 
periments. 
2.2. Assay of lipid peroxidation 
For the assay of NADPH-dependent lipid perox- 
idation, the incubation mixture consisted of liver 
microsomes (1.5 mg/ml), the NADPH-generating 
system (0.55 mM NADP+, 5.5 mM G-6-P, 3.5 U 
G-6-P dehydrogenase and 5.5 mM MgClz), 
1.7 mM ADP, 0.1 mM FeCIs, 130 mM KC1 and 
23 mM NazHPOd-NaH2P04; * pH 7.4. The 
FeC13-ADP mixture was prepared separately 
before the beginning of the experiment. After ther- 
mal equilibration at 37”C, the reaction was in- 
itiated by addition of G-6-P dehydrogenase. 
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Aliquots (1 .O ml) were withdrawn at the indicated 
times and MDA formation was measured. For the 
ascorbate-Fe-induced lipid peroxidation the in- 
cubation mixture consisted of microsomes 
(1.5 mg/ml) pre-heated at 100°C for 8 min, 
2.0 mM ADP, 67 ,uM FeCl3, 0.5 mM ascor- 
bate(Na), 130 mM KC1 and 23 mM Na2HP04- 
NaHzPOd, pH 7.4. The reaction was started by ad- 
ding ascorbate. The ascorbate solution was 
prepared immediately before use and kept under a 
stream of nitrogen. For the t-BuOOH-Fe-induced 
peroxidation, the incubation mixture consisted of 
0.11 mM EDTA, 0.1 mM FeS04, 2.6 mM t- 
BuOOH, 130 mM KCl, microsomes and 
phosphate buffer as in the NADPH system. The 
reaction was started by adding t-BuOOH. The 
nitro compounds were added dissolved in DMFA. 
Controls received the same volume of solvent 
whose concentration never exceeded 1% (v/v); 
DMFA failed to affect the rate of lipid peroxida- 
tion. The incubation mixture’s final volume was 
always 3.0 ml. Incubations were performed in a 
New Brunswick gyratory shaker, at 60 cycles/min 
and 37”C, under air, for the time indicated in sec- 
tion 3. 
2.3. Analytical methods 
MDA and cytochrome P-450 were determined as 
in [9] and [lo], respectively, the corresponding 
values being expressed in nmol MDA (or 
P-450)/mg of microsomal protein. Protein and 
fatty acid content of microsomal membranes was 
determined as indicated in [l l] and [12], respec- 
tively. 
Oxygen uptake was measured with a Gilson Ox- 
ygraph, model 5/6, using the Clark electrode. The 
experimental conditions are described in table 2 
legend. 
2.4. Chemicals 
Nifurtimox and benznidazole were generously 
provided by Bayer, Leverkusen, FRG and 
Hoffmann-La Roche, Basle, Switzerland, respec- 
tively. Nitrofurantoin, chloramphenicol, NADP+, 
G-6-P, G-6-P dehydrogenase (from baker’s yeast), 
ADP (grade IV), Na-ascorbate, t-BuOOH, 
DMFA, thiobarbituric acid and bovine serum 
albumin were purchased from Sigma, St. Louis, 
MO, USA. CO was purchased from Matheson, 
East Rutherford, NJ, USA. Other reagents were of 
analytical grade. 
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2.5. Statistical analysis 
This was performed using Student’s t-test for 
paired values. The values presented are the 
average + SE of three or more independent ex- 
periments. When duplicate samples were 
measured, the experimental values deviated from 
the mean less than 5%. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the effect of increasing concentra- 
tions of nifurtimox on MDA formation by 
microsome samples incubated with either the 
NADPH, the ascorbate or the t-BuOOH systems. 
With the former, nifurtimox effectively inhibited 
MDA formation in a concentration-dependent 
manner, but with the ascorbate and the t-BuOOH 
systems, nifurtimox scarcely inhibited lipid perox- 
idation. In close agreement with the inhibition of 
MDA accumulation, nifurtimox (i) prevented the 
destruction of microsomal polyenoic fatty acids 
(table 1) and (ii) inhibited the peroxidation-related 
[13] destruction of cytochrome P-450 (fig.2). 
Comparison of several nitro compounds for 
their action on MDA formation revealed the 
greater activity of the two nitrofurans (fig.3). The 
calculated 50% inhibitory concentrations were (in 
I I I I I I I I 
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Fig.1. Effect of nifurtimox on MDA formation by 
microsomes incubated with the NADPH system 
(NADPH); the ascorbate system (AS) and the t-BuOOH 
system (BuOOH). Experimental conditions were as 
described in section 2; incubation time (min): 60 
(NADPH), 90 (AS); 15 (BuOOH). * P < 0.02; ** P < 
0.01, as compared with the sample without nifurtimox. 
The bar over the experimental points represents SE. 
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,uM): 85 (nifurtimox), 175 (nitrofurantoin) and 
> 1000 (benznidazole and chloramphenicol), 
which correlated, at least qualitatively, with the ef- 
fect of the same nitro compounds on microsomal 
NADPH-oxidase activity (table 2). Nifurtimox in- 
hibition of the t-BuOOH-dependent lipid perox- 
idation increased significantly when NADPH was 
added to the incubation mixture (table 3). 
Our observations (figs l-3 and table 1) clearly 
show the inhibitory effect of nifurtimox on lipid 
peroxidation. Similar inhibitions of MDA ac- 
cumulation were obtained with nitrofurantoin but 
not with benznidazole and chloramphenicol 
(fig.3), which stresses the importance of the 
nitrofuran structure for peroxidation inhibition. 
Since reducing equivalents are consumed by both 
lipid peroxidation and nitro compound reduction, 
it seems reasonable to assume that nifurtimox and 
nitrofurantoin diverted electrons that would other- 
wise initiate the former process, thus inhibiting it 
[ 14-161. This hypothesis is supported by the 
absence of extensive effects of nifurtimox on the 
ascorbate- and t-BuOOH-dependent lipid perox- 
Table 1 
Effect of incubation with NADPH and nifurtimox on 
the fatty acid composition of microsomal lipids 
Fatty 
acid 
NADPH-generating system 
Omitted Added 
Nifurtimox Nifurtimox 
omitted added 
16:0 
18:0 
18: In9 
18:2n6 
20 : 4n6 
20:5n3 
22 : 6n3 
20 : dn6 
18: ln9 
23.1 f 2.1 29.9 + 1.0 26.5 r+ 1.1 
26.8 k 1.7 34.5 +I 3.9 33.1 k 5.9 
8.6 f 0.8 12.1 f 0.3 10.1 k 0.6 
11.6 f 0.6 10.6 f 1.1 11.2 +_ 1.1 
20.8 + 1.3 9.8 + 1.6 12.3 + 1.2” 
3.4 f 0.5 1.5 * 0.5 2.4 k 0.9” 
6.0 f 0.9 2.0 * 1.2 4.4 + 2.5” 
2.42 -t 0.27 0.81 2 0.03 1.23 f 0.13” 
22 : 6n3 
0.70 k 0.12 0.16 k 0.09 0.44 + 0.02” 
18: ln9 
The experimental conditions were as described in section 
2; 53 PM nifurtimox; 1 h incubation; values represent 
average wt% occurrence -+ SE (n = 4 experiments). 
a kO.05 for samples with nifurtimox vs samples 
without nifurtimox 
n MoA q P-450 
Fig.2. Effect of nifurtimox on cytochrome P-450 
content and MDA formation in microsomal samples 
incubated with the NADPH system (NADPH). 
Experimental conditions were as described in section 2; 
53 pM nifurtimox; 60 min incubation. * P < 0.05 for 
samples with nifurtimox vs samples without nifurtimox. 
CH 
NITRO COMPOUND (mM I 
Fig.3. Effect of nifurtimox (NX), nitrofurantoin (NA), 
benznidazole (BE) and chloramphenicol (CH) on lipid 
peroxidation in microsomes incubated with the NADPH 
system. Experimental conditions were as described in 
section 2. Measurements in duplicate. 60 min 
incubation. 
idations (fig.1) and the different effects of nitro 
compounds on microsomal NADPH-oxidase ac- 
tivity (table 2). Since redox cycling of the assayed 
nitro compounds generates the corresponding 
nitro anions [5-71, their action as electron traps 
must depend on their rate of oxidation by oxygen, 
which was apparently faster for the nitrofurans 
199 
Volume 220, number 1 FEBS LETTERS August 1987 
Table 2 ACKNOWLEDGEMENTS 
Effect of nitro compounds on microsomal NADPH- 
oxidase activity 
Nitro compound Oxygen uptake 
(200 PM) nmol Oz/min 
(~ mg of protein i 
None 7.1 + 0.3 
Nifurtimox 20.4 + 1.7” 
Nitrofurantoin 37.0 + 0.7a 
Benznidazole 8.9 + 0.4 
Chloramphenicol 7.3 * 0.4 
Oxygen uptake measured polarographically, for 
4-5 min; the incubation mixture contained NADPH- 
generating system, 130 mM KCI, 23 mM phosphate 
buffer, pH 7.4, and microsomes (1.1 mg/ml of protein). 
The nitro compounds were dissolved in DMFA; all 
samples contained 64 mM DMFA. Other experimental 
conditions were as described in section 2. Values 
represent the average ? SE of 4 measurements. ’ P < 
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